Martin Schnelle

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

Florian Strasser, Diana Lüftner, Kurt Possinger et al. · Journal of Clinical Oncology · 2006 · 402 citations · Full text

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

Claude Vaney, Monika Heinzel‐Gutenbrunner, P Jobin et al. · Multiple Sclerosis Journal · 2004 · 256 citations

Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of ??9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract

Thomas Nadulski, Fritz Pragst, Gordon Weinberg et al. · Therapeutic Drug Monitoring · 2005 · 179 citations

Simultaneous and Sensitive Analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in Plasma after Oral Application of Small Doses of THC and Cannabis Extract

Thomas Nadulski, Frank Sporkert, Martin Schnelle et al. · Journal of Analytical Toxicology · 2005 · 141 citations · Full text

Survey on the Medical Use of Cannabis and THC in Germany

Franjo Grotenhermen, Martin Schnelle · Journal of Cannabis Therapeutics · 2003 · 31 citations

Substance Use, Cannabis Products, Drug Policy +20